241 related articles for article (PubMed ID: 8223596)
41. A yeast phosphofructokinase insensitive to the allosteric activator fructose 2,6-bisphosphate. Glycolysis/metabolic regulation/allosteric control.
Heinisch JJ; Boles E; Timpel C
J Biol Chem; 1996 Jul; 271(27):15928-33. PubMed ID: 8663166
[TBL] [Abstract][Full Text] [Related]
42. Kinetic modelling of yeast phosphofructokinase.
Reuter R; Eschrich K; Schellenberger W; Hofmann E
Acta Biol Med Ger; 1979; 38(8):1067-79. PubMed ID: 161131
[TBL] [Abstract][Full Text] [Related]
43. Differences in the degradation of yeast phosphofructokinase by proteinases A and B from yeast.
Huse K; Kopperschläger G; Hofmann E
Biochem J; 1976 Jun; 155(3):721-3. PubMed ID: 133676
[TBL] [Abstract][Full Text] [Related]
44. Evidence for phosphorylation of yeast phosphofructokinase.
Huse K; Jergil B; Schwidop WD; Kopperschläger G
FEBS Lett; 1988 Jul; 234(1):185-8. PubMed ID: 2968917
[TBL] [Abstract][Full Text] [Related]
45. A single point mutation leads to an instability of the hetero-octameric structure of yeast phosphofructokinase.
Kirchberger J; Edelmann A; Kopperschläger G; Heinisch JJ
Biochem J; 1999 Jul; 341 ( Pt 1)(Pt 1):15-23. PubMed ID: 10377240
[TBL] [Abstract][Full Text] [Related]
46. Effects of trypsin on yeast phosphofructokinase.
Freyer R; Böhme HJ; Hofmann E
Acta Biol Med Ger; 1974; 32(6):593-9. PubMed ID: 4278551
[No Abstract] [Full Text] [Related]
47. Interaction of calmodulin with muscle phosphofructokinase. Interplay with metabolic effectors of the enzyme under physiological conditions.
Mayr GW
Eur J Biochem; 1984 Sep; 143(3):521-9. PubMed ID: 6236976
[TBL] [Abstract][Full Text] [Related]
48. Fructose-2,6-bisphosphate increases the binding affinity of yeast phosphofructokinase to AMP.
Kessler R; Nissler K; Schellenberger W; Hofmann E
Biochem Biophys Res Commun; 1982 Jul; 107(2):506-10. PubMed ID: 6215040
[No Abstract] [Full Text] [Related]
49. The susceptibility towards proteolysis of intermediates during the renaturation of yeast phosphoglycerate mutase.
Johnson CM; Price NC
Biochem J; 1986 Jun; 236(2):617-20. PubMed ID: 3019321
[TBL] [Abstract][Full Text] [Related]
50. Analysis of the structural core of the human estrogen receptor ligand binding domain by selective proteolysis/mass spectrometric analysis.
Seielstad DA; Carlson KE; Kushner PJ; Greene GL; Katzenellenbogen JA
Biochemistry; 1995 Oct; 34(39):12605-15. PubMed ID: 7548010
[TBL] [Abstract][Full Text] [Related]
51. A proteolyzed derivative of Escherichia coli phosphofructokinase is no longer sensitive to allosteric effectors and still shows cooperativity in substrate binding.
Le Bras G; Garel JR
Biochemistry; 1982 Dec; 21(26):6656-60. PubMed ID: 6218818
[TBL] [Abstract][Full Text] [Related]
52. Purification and properties of adductor muscle phosphofructokinase from the oyster, Crassostrea virginica. The aerobic/anaerobic transition: role of arginine phosphate in enzyme control.
Storey KB
Eur J Biochem; 1976 Nov; 70(2):331-7. PubMed ID: 12948
[TBL] [Abstract][Full Text] [Related]
53. Substrate- and effector-induced conformational changes in phosphofructokinase from white muscle of rainbow trout (Oncorhynchus mykiss): a fluorescence study.
Su JY; Storey KB
Biochem Cell Biol; 1993; 71(5-6):255-9. PubMed ID: 8274266
[TBL] [Abstract][Full Text] [Related]
54. Fructose 2-phosphate, an intermediate of the dephosphorylation of fructose 2,6-bisphosphate with a purified yeast enzyme.
Purwin C; Laux M; Holzer H
Eur J Biochem; 1987 Apr; 164(1):27-30. PubMed ID: 2951255
[TBL] [Abstract][Full Text] [Related]
55. Properties of phosphofructokinase from the mucosa of rat jejunum and their relation to the lack of Pasteur effect.
Tejwani GA; Ramaiah A
Biochem J; 1971 Nov; 125(2):507-14. PubMed ID: 4259410
[TBL] [Abstract][Full Text] [Related]
56. Reciprocal regulation of fructose 1,6-bisphosphatase and phosphofructokinase by fructose 2,6-bisphosphate in swine kidney.
Muniyappa K; Leibach FH; Mendicino J
Life Sci; 1983 Jan; 32(3):271-8. PubMed ID: 6218355
[TBL] [Abstract][Full Text] [Related]
57. The regulation of phosphofructokinase in epimastigote Trypanosoma cruzi.
Taylor M; Gutteridge WE
FEBS Lett; 1986 Jun; 201(2):262-6. PubMed ID: 3011512
[TBL] [Abstract][Full Text] [Related]
58. Desensitization of muscle phosphofructokinase to ATP inhibition by removal of a carboxyl-terminal heptadecapeptide.
Valaitis AP; Foe LG; Kemp RG
J Biol Chem; 1987 Apr; 262(11):5044-8. PubMed ID: 2951376
[TBL] [Abstract][Full Text] [Related]
59. Unique PFK regulatory property from some mosquito vectors of disease, and from Drosophila melanogaster.
Nunes RD; Romeiro NC; De Carvalho HT; Moreira JR; Sola-Penna M; Silva-Neto MA; Braz GR
Parasit Vectors; 2016 Feb; 9():107. PubMed ID: 26911930
[TBL] [Abstract][Full Text] [Related]
60. Binding of nucleotides AMP and ATP to yeast phosphofructokinase:evidence for distinct catalytic and regulatory subunits.
Laurent M; Chaffotte AF; Tenu JP; Roucous C; Seydoux FJ
Biochem Biophys Res Commun; 1978 Feb; 80(3):646-52. PubMed ID: 147082
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
